(Total Views: 198)
Posted On: 02/06/2021 7:36:03 PM
Post# of 36564
Well, with over 1 billion folks in China vs some 300 million plus in the US, GNBT / NGIO is still sitting good where they are with the China deal.
Add in the Malaysia deal and you get another huge population umbrella, not just for COVID, but for other vaccines as well for both.
So, the overseas market will be their go to probably on this for the meantime I would think.
I wonder with the testing next week, if that will provide the information acceptable for the China deal to start manufacturing and maybe the Malaysia deal to push forward finally if the China deal accepts it.
Add in the Malaysia deal and you get another huge population umbrella, not just for COVID, but for other vaccines as well for both.
So, the overseas market will be their go to probably on this for the meantime I would think.
I wonder with the testing next week, if that will provide the information acceptable for the China deal to start manufacturing and maybe the Malaysia deal to push forward finally if the China deal accepts it.
(1)
(0)
